Association of Interleukin-28b- Rs8099917 with Response to Treatment with Interferon Α-2b & Ribavirin in C. Hepatitis C pts

Authors

  • Rahman Shah, Saifullah Khan Khalil, Umar Aleem, Falak Naz, Naimat Ullah, Najeeb Ullah

DOI:

https://doi.org/10.53350/pjmhs2216328

Keywords:

Hepatocellular carcinoma, Cirrhosis, Interferon, Ribavirin, IL28-B

Abstract

Aim: To determine the association of interleukin-28b- RS8099917 with response to treatment with interferon α-2b & ribavirin in chronic hepatitis C patients

Methods: A case control study has been designed. Those who respond to standard therapy were classified as responders while those who didn’t respond to standard regimen were referred as non-responders. A total of 219 (95 males, 124 females) patients were recruited. All the demographics and biochemical data were recorded that includes age, ALT and viral load. The data were analyzed using SPSS version 16.

Results: The data reveals that polymorphism of IL28B- RS8099917 does not affect the treatment outcome (p-value=0.65, OR=1.52). Similarly, both responders and non-responder groups were not consistent with HWE with p-value 0.9 and 0.23 respectively.

Conclusion: polymorphism of IL28B- RS8099917 does not affect the treatment outcome Large multicenter studies must be conducted with large sample size to further validate our findings.

Downloads

How to Cite

Rahman Shah, Saifullah Khan Khalil, Umar Aleem, Falak Naz, Naimat Ullah, Najeeb Ullah. (2022). Association of Interleukin-28b- Rs8099917 with Response to Treatment with Interferon Α-2b & Ribavirin in C. Hepatitis C pts. Pakistan Journal of Medical & Health Sciences, 16(03), 28. https://doi.org/10.53350/pjmhs2216328

Issue

Vol. 16 No. 03 (2022): Pakistan Journal of Medical & Health Sciences

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.